{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:16:24Z","timestamp":1774289784013,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T00:00:00Z","timestamp":1408233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00520-014-2364-3","type":"journal-article","created":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T01:26:49Z","timestamp":1408152409000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors"],"prefix":"10.1007","volume":"23","author":[{"given":"Temitope","family":"Olufade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy J.","family":"Helzlsouer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,17]]},"reference":[{"issue":"1","key":"2364_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","volume":"76","author":"WF Anderson","year":"2002","unstructured":"Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76(1):27\u201336","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2364_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/cbt.3.9.1128","volume":"3","author":"G Grana","year":"2004","unstructured":"Grana G (2004) Shifting paradigms in hormonal therapy for breast cancer. Cancer Biol Ther 3(9):797\u2013805","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"2364_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/1568011043352669","volume":"4","author":"J Narashimamurthy","year":"2004","unstructured":"Narashimamurthy J, Rao AR, Sastry GN (2004) Aromatase inhibitors: a new paradigm in breast cancer treatment. Curr Med Chem Anticancer Agents 4(6):523\u2013534","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"3","key":"2364_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/17455057.1.3.309","volume":"1","author":"A Howell","year":"2005","unstructured":"Howell A (2005) Anastrozole: a new gold standard of hormonal treatment for breast cancer? Womens Health (Lond Engl) 1(3):309\u2013322","journal-title":"Womens Health (Lond Engl)"},{"key":"2364_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J et al (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28:509\u2013518","journal-title":"J Clin Oncol"},{"issue":"12","key":"2364_CR6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1470-2045(11)70270-4","volume":"12","author":"MM Regan","year":"2011","unstructured":"Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L et al (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1\u201398 randomised clinical trial at 8\u2009\u00b7\u20091\u00a0years median follow-up. Lancet Oncol 12(12):1101\u20131108","journal-title":"Lancet Oncol"},{"issue":"12","key":"2364_CR7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","volume":"11","author":"J Cuzick","year":"2010","unstructured":"Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135\u20131141","journal-title":"Lancet Oncol"},{"issue":"3","key":"2364_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-007-9558-z","volume":"107","author":"EJ Aiello","year":"2008","unstructured":"Aiello EJ, Buist DS, Wagner EH, Tuzzio L, Greene SM, Lamerato LE et al (2008) Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat 107(3):397\u2013403","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2364_CR9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/cncr.24271","volume":"115","author":"Y Shen","year":"2009","unstructured":"Shen Y, Dong W, Feig BW, Ravdin P, Theriault RL, Giordano SH (2009) Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004. Cancer 115(10):2041\u20132051","journal-title":"Cancer"},{"issue":"17","key":"2364_CR10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","volume":"103","author":"E Amir","year":"2011","unstructured":"Amir E, Seruga B, Niraula S, Carlsson L, Oca\u00f1a A (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103(17):1299\u20131309","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2364_CR11","doi-asserted-by":"crossref","first-page":"80.e1","DOI":"10.1016\/j.ajog.2008.07.062","volume":"200","author":"SR Duffy","year":"2009","unstructured":"Duffy SR, Distler W, Howell A, Cuzick J, Baum M (2009) A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial. Am J Obstet Gynecol 200(1):80.e1\u2013e7","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"2364_CR12","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/cncr.24508","volume":"115","author":"RK Hernandez","year":"2009","unstructured":"Hernandez RK, S\u00f8rensen HT, Pedersen L, Jacobsen J, Lash TL (2009) Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Cancer 115(19):4442\u20134449","journal-title":"Cancer"},{"key":"2364_CR13","doi-asserted-by":"crossref","unstructured":"Khan QJ, O'Dea AP, Sharma P (2010) Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. J Oncol pii: 654348","DOI":"10.1155\/2010\/654348"},{"key":"2364_CR14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/era.11.96","volume":"11","author":"F Tomao","year":"2011","unstructured":"Tomao F, Spinelli G, Vici P, Pisanelli GC, Cascialli G, Frati L et al (2011) Current role and safety profile of aromatase inhibitors in early breast cancer. Expert Rev Anticancer Ther 11:1253\u20131263","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"2364_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2818","volume":"13","author":"S Gaillard","year":"2011","unstructured":"Gaillard S, Stearns V (2011) Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res 13(2):205","journal-title":"Breast Cancer Res"},{"key":"2364_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"NL Henry","year":"2008","unstructured":"Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J et al (2008) Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111:365\u2013372","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2364_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4174\/jkss.2013.85.5.205","volume":"85","author":"JY Park","year":"2013","unstructured":"Park JY, Lee SK, Bae SY, Kim J, Kim MK, Kil WH et al (2013) Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors. J Korean Surg Soc 85(5):205\u2013211","journal-title":"J Korean Surg Soc"},{"issue":"12","key":"2364_CR18","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/acr.21756","volume":"4","author":"O Singer","year":"2012","unstructured":"Singer O, Cigler T, Moore AB, Levine AB, Hentel K, Belfi L et al (2012) Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study. Arthritis Care Res (Hoboken) 4(12):1910\u20131918","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"2364_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3747\/co.v18i6.909","volume":"18","author":"A Robidoux","year":"2011","unstructured":"Robidoux A, Rich E, Bureau NJ, Mader S, Laperri\u00e8re D, Bail M et al (2011) A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy. Curr Oncol 18(6):285\u2013294","journal-title":"Curr Oncol"},{"issue":"2","key":"2364_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3816\/CBC.2010.n.019","volume":"10","author":"G Moxley","year":"2010","unstructured":"Moxley G (2010) Rheumatic disorders and functional disability with aromatase inhibitor therapy. Clin Breast Cancer 10(2):144\u2013147","journal-title":"Clin Breast Cancer"},{"key":"2364_CR21","author":"KM Kidwell","year":"2014","unstructured":"Kidwell KM, Harte SE, Hayes DF, Storniolo AM, Carpenter J, Flockhart DA et al (2014) Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer. doi: 10.1037\/ a0028240","journal-title":"Cancer"},{"issue":"12","key":"2364_CR22","first-page":"1681","volume":"84","author":"T Sueblinvong","year":"2001","unstructured":"Sueblinvong T, Taechakraichana N, Phupong V (2001) Prevalence of climacteric symptoms according to years after menopause. J Med Assoc Thai 84(12):1681\u20131691","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"2364_CR23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1479-828X.2009.00955.x","volume":"49","author":"L Bairy","year":"2009","unstructured":"Bairy L, Adiga S, Bhat P, Bhat R (2009) Prevalence of menopausal symptoms and quality of life after menopause in women from South India. Aust N Z J Obstet Gynaecol 49(1):106\u2013109","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"2364_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.ajp.0000208249.07949.d5","volume":"22","author":"SA Dugan","year":"2006","unstructured":"Dugan SA, Powell LH, Kravitz HM, Everson Rose SA, Karavolos K, Luborsky J (2006) Musculoskeletal pain and menopausal status. Clin J Pain 22(4):325\u2013331","journal-title":"Clin J Pain"},{"key":"2364_CR25","doi-asserted-by":"crossref","unstructured":"Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, et al., Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 110:230\u2013240","DOI":"10.1097\/01.AOG.0000270153.59102.40"},{"issue":"1","key":"2364_CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-011-1729-2","volume":"131","author":"KJ Helzlsouer","year":"2012","unstructured":"Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E (2012) A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms. Breast Cancer Res Treat 131(1):277\u2013285","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2364_CR27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.berh.2007.03.001","volume":"21","author":"EH T\u00fcz\u00fcn","year":"2007","unstructured":"T\u00fcz\u00fcn EH (2007) Quality of life in chronic musculoskeletal pain.Best. Pract Res Clin Rheumatol 21(3):567\u2013579","journal-title":"Pract Res Clin Rheumatol"},{"issue":"1","key":"2364_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-011-1943-y","volume":"133","author":"H Takei","year":"2012","unstructured":"Takei H, Ohsumi S, Shimozuma K, Takehara M, Suemasu K, Ohashi Y et al (2012) Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04). Breast Cancer Res Treat 133(1):227\u2013236","journal-title":"Breast Cancer Res Treat"},{"key":"2364_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-011-1400-y","volume":"127","author":"S Ohsumi","year":"2011","unstructured":"Ohsumi S, Shimozuma K, Ohashi Y, Shinji M, Hozumi Y, Mukai H et al (2011) Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1\u20134 years: N-SAS BC 03. Breast Cancer Res Treat 127:143\u2013152","journal-title":"Breast Cancer Res Treat"},{"key":"2364_CR30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ctrv.2008.04.001","volume":"34","author":"C Buijs","year":"2008","unstructured":"Buijs C, de Vries EG, Mourits MJ, Willemse PH (2008) The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 34:640\u2013655","journal-title":"Cancer Treat Rev"},{"key":"2364_CR31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/bjc.2012.43","volume":"106","author":"LJ Fallowfield","year":"2012","unstructured":"Fallowfield LJ, Kilburn LS, Langridge C, Snowdon CF, Bliss JM, Coombes RC, Trial Steering Committee IES (2012) Long-term assessment of quality of life in the Intergroup Exemestane Study: 5\u00a0years post-randomisation. Br J Cancer 106:1062\u20131067","journal-title":"Br J Cancer"},{"key":"2364_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","volume":"100","author":"D Cellar","year":"2006","unstructured":"Cellar D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A (2006) Quality of life of postmenopausal women in the ATAC (\"Arimidex\", tamoxifen, alone or in combination) trial after completion of 5\u00a0years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100:273\u2013284","journal-title":"Breast Cancer Res Treat"},{"key":"2364_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-012-2028-2","volume":"34","author":"JG Nes van","year":"2012","unstructured":"van Nes JG, Fontein DB, Hille ET, Voskuil DW, van Leeuwen FE, de Haes JC et al (2012) Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Res Treat 34:267\u2013276","journal-title":"Breast Cancer Res Treat"},{"key":"2364_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"2364_CR35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00005650-198807000-00007","volume":"26","author":"AL Stewart","year":"1988","unstructured":"Stewart AL, Hays RD, Aare JE Jr (1988) The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care 26:724\u2013732","journal-title":"Med Care"},{"key":"2364_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF02966719","volume":"10","author":"T Okamoto","year":"2003","unstructured":"Okamoto T, Shimozuma K, Katsumata N, Koike M, Hisashige A, Tanaka K et al (2003) Task Force of the Japanese Breast Cancer Society for 'The Development of Guidelines for Quality of Life Assessment Studies of Breast Cancer Patients'. Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan. Breast Cancer 10:204\u2013213","journal-title":"Breast Cancer"},{"key":"2364_CR37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11136-004-2393-3","volume":"14","author":"R Pinar","year":"2005","unstructured":"Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14:259\u2013264","journal-title":"Qual Life Res"},{"key":"2364_CR38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pain.2004.09.014","volume":"113","author":"SM Paul","year":"2005","unstructured":"Paul SM, Zelman DC, Smith M, Miaskowski C (2005) Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 113:37\u201344","journal-title":"Pain"},{"key":"2364_CR39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1682\/JRRD.2006.05.0051","volume":"44","author":"KR Jones","year":"2007","unstructured":"Jones KR, Vojir CP, Hutt E, Fink R (2007) Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev 44:305\u2013314","journal-title":"J Rehabil Res Dev"},{"key":"2364_CR40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1188\/10.CJON.379-382","volume":"14","author":"L Winters","year":"2010","unstructured":"Winters L, Habin K, Flanagan J, Cashavelly BJ (2010) \"I feel like I am 100\u00a0years old!\" managing arthralgias from aromatase inhibitors. Clin J Oncol Nurs 14:379\u2013382","journal-title":"Clin J Oncol Nurs"},{"key":"2364_CR41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1207\/S15324796ABM2501_03","volume":"25","author":"SJ Vickberg","year":"2003","unstructured":"Vickberg SJ (2003) The Concerns About Recurrence Scale (CARS): a systematic measure of women\u2019s fears about the possibility of breast cancer recurrence. Ann Behave Med 25:16\u201324","journal-title":"Ann Behave Med"},{"key":"2364_CR42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11764-009-0082-5","volume":"3","author":"S Lebel","year":"2009","unstructured":"Lebel S, Rosberger Z, Edgar L, Devins GM (2009) Emotional distress impacts fear of the future among breast cancer survivors not the reverse. J Cancer Surviv 3:117\u2013127","journal-title":"J Cancer Surviv"},{"key":"2364_CR43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pon.1340","volume":"17","author":"MH Beuken-van Everdingen van den","year":"2008","unstructured":"van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J (2008) Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology 17:1137\u20131145","journal-title":"Psychooncology"},{"key":"2364_CR44","doi-asserted-by":"crossref","unstructured":"Green CR, Hart-Johnson T, Loeffler DR (2011) Cancer-related chronic pain: examining quality of life in diverse cancer survivors. 117:1994\u20132003","DOI":"10.1002\/cncr.25761"},{"key":"2364_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1188\/11.ONF.279-288","volume":"38","author":"KT Ashing Giwa","year":"2011","unstructured":"Ashing Giwa KT, Lim JW (2011) Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum 38:279\u2013288","journal-title":"Oncol Nurs Forum"},{"key":"2364_CR46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11764-009-0097-y","volume":"3","author":"NK Janz","year":"2009","unstructured":"Janz NK, Mujahid MS, Hawley ST, Griggs JJ, Alderman A, Hamilton AS, Graff J, Katz SJ (2009) Racial\/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv 3:212\u2013222","journal-title":"J Cancer Surviv"},{"issue":"2","key":"2364_CR47","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.clbc.2013.10.003","volume":"14","author":"PK Morrow","year":"2014","unstructured":"Morrow PK, Broxson AC, Munsell MF, Basen-Enquist K, Rosenblum CK, Schover LR et al (2014) Effect of age and race on quality of life in young breast cancer survivors. Clin Breast Cancer 14(2):e21\u2013e31","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"2364_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-006-9479-2","volume":"106","author":"DJ Bowen","year":"2007","unstructured":"Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K et al (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85\u201395","journal-title":"Breast Cancer Res Treat"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2364-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2364-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:14:48Z","timestamp":1565748888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2364-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,17]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2364-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,17]]}}}